246 related articles for article (PubMed ID: 23277475)
1. Ablation of cardiac myosin-binding protein-C accelerates contractile kinetics in engineered cardiac tissue.
de Lange WJ; Grimes AC; Hegge LF; Ralphe JC
J Gen Physiol; 2013 Jan; 141(1):73-84. PubMed ID: 23277475
[TBL] [Abstract][Full Text] [Related]
2. E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction.
De Lange WJ; Grimes AC; Hegge LF; Spring AM; Brost TM; Ralphe JC
J Gen Physiol; 2013 Sep; 142(3):241-55. PubMed ID: 23980194
[TBL] [Abstract][Full Text] [Related]
3. Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice.
Stöhr A; Friedrich FW; Flenner F; Geertz B; Eder A; Schaaf S; Hirt MN; Uebeler J; Schlossarek S; Carrier L; Hansen A; Eschenhagen T
J Mol Cell Cardiol; 2013 Oct; 63():189-98. PubMed ID: 23896226
[TBL] [Abstract][Full Text] [Related]
4. Altered C10 domain in cardiac myosin binding protein-C results in hypertrophic cardiomyopathy.
Kuster DWD; Lynch TL; Barefield DY; Sivaguru M; Kuffel G; Zilliox MJ; Lee KH; Craig R; Namakkal-Soorappan R; Sadayappan S
Cardiovasc Res; 2019 Dec; 115(14):1986-1997. PubMed ID: 31050699
[TBL] [Abstract][Full Text] [Related]
5. The HCM-linked W792R mutation in cardiac myosin-binding protein C reduces C6 FnIII domain stability.
Smelter DF; de Lange WJ; Cai W; Ge Y; Ralphe JC
Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1179-H1191. PubMed ID: 29451820
[TBL] [Abstract][Full Text] [Related]
6. Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes.
Pohlmann L; Kröger I; Vignier N; Schlossarek S; Krämer E; Coirault C; Sultan KR; El-Armouche A; Winegrad S; Eschenhagen T; Carrier L
Circ Res; 2007 Oct; 101(9):928-38. PubMed ID: 17823372
[TBL] [Abstract][Full Text] [Related]
7. Phosphoregulation of Cardiac Inotropy via Myosin Binding Protein-C During Increased Pacing Frequency or β1-Adrenergic Stimulation.
Tong CW; Wu X; Liu Y; Rosas PC; Sadayappan S; Hudmon A; Muthuchamy M; Powers PA; Valdivia HH; Moss RL
Circ Heart Fail; 2015 May; 8(3):595-604. PubMed ID: 25740838
[TBL] [Abstract][Full Text] [Related]
8. Molecular effects of the myosin activator omecamtiv mecarbil on contractile properties of skinned myocardium lacking cardiac myosin binding protein-C.
Mamidi R; Gresham KS; Li A; dos Remedios CG; Stelzer JE
J Mol Cell Cardiol; 2015 Aug; 85():262-72. PubMed ID: 26100051
[TBL] [Abstract][Full Text] [Related]
9. Neonatal mouse-derived engineered cardiac tissue: a novel model system for studying genetic heart disease.
de Lange WJ; Hegge LF; Grimes AC; Tong CW; Brost TM; Moss RL; Ralphe JC
Circ Res; 2011 Jun; 109(1):8-19. PubMed ID: 21566213
[TBL] [Abstract][Full Text] [Related]
10. Dissociation of structural and functional phenotypes in cardiac myosin-binding protein C conditional knockout mice.
Chen PP; Patel JR; Powers PA; Fitzsimons DP; Moss RL
Circulation; 2012 Sep; 126(10):1194-205. PubMed ID: 22829020
[TBL] [Abstract][Full Text] [Related]
11. cMyBP-C ablation in human engineered cardiac tissue causes progressive Ca2+-handling abnormalities.
De Lange WJ; Farrell ET; Hernandez JJ; Stempien A; Kreitzer CR; Jacobs DR; Petty DL; Moss RL; Crone WC; Ralphe JC
J Gen Physiol; 2023 Apr; 155(4):. PubMed ID: 36893011
[TBL] [Abstract][Full Text] [Related]
12. Ablation of myosin-binding protein-C accelerates force development in mouse myocardium.
Stelzer JE; Fitzsimons DP; Moss RL
Biophys J; 2006 Jun; 90(11):4119-27. PubMed ID: 16513777
[TBL] [Abstract][Full Text] [Related]
13. Contractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy.
Barefield D; Kumar M; de Tombe PP; Sadayappan S
Am J Physiol Heart Circ Physiol; 2014 Mar; 306(6):H807-15. PubMed ID: 24464755
[TBL] [Abstract][Full Text] [Related]
14. A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunction.
Kuster DW; Govindan S; Springer TI; Martin JL; Finley NL; Sadayappan S
J Biol Chem; 2015 Feb; 290(9):5855-67. PubMed ID: 25583989
[TBL] [Abstract][Full Text] [Related]
15. Ablation of cardiac myosin binding protein-C disrupts the super-relaxed state of myosin in murine cardiomyocytes.
McNamara JW; Li A; Smith NJ; Lal S; Graham RM; Kooiker KB; van Dijk SJ; Remedios CGD; Harris SP; Cooke R
J Mol Cell Cardiol; 2016 May; 94():65-71. PubMed ID: 27021517
[TBL] [Abstract][Full Text] [Related]
16. Acceleration of crossbridge kinetics by protein kinase A phosphorylation of cardiac myosin binding protein C modulates cardiac function.
Tong CW; Stelzer JE; Greaser ML; Powers PA; Moss RL
Circ Res; 2008 Oct; 103(9):974-82. PubMed ID: 18802026
[TBL] [Abstract][Full Text] [Related]
17. Phosphomimetic cardiac myosin-binding protein C partially rescues a cardiomyopathy phenotype in murine engineered heart tissue.
Dutsch A; Wijnker PJM; Schlossarek S; Friedrich FW; Krämer E; Braren I; Hirt MN; Brenière-Letuffe D; Rhoden A; Mannhardt I; Eschenhagen T; Carrier L; Mearini G
Sci Rep; 2019 Dec; 9(1):18152. PubMed ID: 31796859
[TBL] [Abstract][Full Text] [Related]
18. Cardiac myosin binding protein-C phosphorylation accelerates β-cardiac myosin detachment rate in mouse myocardium.
Tanner BCW; Previs MJ; Wang Y; Robbins J; Palmer BM
Am J Physiol Heart Circ Physiol; 2021 May; 320(5):H1822-H1835. PubMed ID: 33666504
[TBL] [Abstract][Full Text] [Related]
19. In vivo left ventricular functional capacity is compromised in cMyBP-C null mice.
Brickson S; Fitzsimons DP; Pereira L; Hacker T; Valdivia H; Moss RL
Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1747-54. PubMed ID: 17122190
[TBL] [Abstract][Full Text] [Related]
20. Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice.
Barefield D; Kumar M; Gorham J; Seidman JG; Seidman CE; de Tombe PP; Sadayappan S
J Mol Cell Cardiol; 2015 Feb; 79():234-43. PubMed ID: 25463273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
